Lepu Biopharma Co. Ltd. Class H (HK:2157) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lepu Biopharma Co., Ltd. has entered into a CDMO Services Framework Agreement with Lepu Medical, aiming to provide technical services and equipment for GLP-1 and related products. As a connected transaction, it requires approval from independent shareholders and is subject to specific reporting and review requirements. An Extraordinary General Meeting will be held to consider and approve this agreement.
For further insights into HK:2157 stock, check out TipRanks’ Stock Analysis page.